Skip to main content

Genus Capital Management Inc.

Position in LLY — ELI LILLY & Co

CIK 1532385 VANCOUVER, A1

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$5,562,956
+$2,389,750 QoQ
Shares Held
4,638
+34.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1,631
of 4,605 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$2,406,213
PutShares
2,716

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. LLY ranks #5 (11.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 LLY
ELI LILLY & Co
This page
4,638 $5,562,956

All Filings in LLY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,562,956 4,638
2026-03-31 $3,173,206 3,450
2025-12-31 $4,943,528 4,600
2025-03-31 $951,448 1,152
2024-09-30 $2,406,213 2,716
2024-06-30 $11,018,474 12,170
2024-03-31 $4,147,304 5,331
2023-12-31 $2,000,581 3,432
2023-09-30 $10,947,246 20,381
2023-06-30 $12,305,097 26,238